Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000605794 | SCV000722647 | likely benign | not specified | 2017-09-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000605794 | SCV000863372 | likely benign | not specified | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000872214 | SCV001154964 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | SYNE1: BP4, BS1, BS2 |
Invitae | RCV002064046 | SCV002384738 | benign | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2021-10-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927993 | SCV004741055 | benign | SYNE1-related condition | 2020-01-27 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |